Split doses of Methotrexate in patients with moderate to severe Psoriasis M.J.M. Rodríguez-Zúñiga, F. Cortez-Franco, E. Qujiano-Gomero

Updated Position of the Spanish Psoriasis Group (GPs) on the Use of Biosimilar Drugs in Moderate to Severe Psoriasis R. Ruiz-Villaverde, M. Galán-Gutiérrez, M. Llamas-Velasco, L. Salgado-Boquete, L. Puig, P. de la Cueva, J.M. Carrascosa

Long-term real-world persistence of guselkumab in patients with moderate-to-severe psoriasis J. Borrás-Blasco, R. Alcala, A. Valcuende-Rosique, S. Cornejo